Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-27 10:05:17 - browse：6497

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： WATCH: Why do fingernails fall off when they're damaged?

WSS

The science behind Janet Jackson's pregnancy at 49

Vertigo drug brings hope for rare neuron disorder, Niemann

Apple Vision Pro: A first look at health apps on the new VR headset

Gene therapy has helped boys walk. Can scientists keep it that way?

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Weight bias in eating disorder treatment complicated by new weight loss drugs

Wikipedia

Wikipedia

hotspot

Virginia high school admissions case could be legal follow

Why drug prescriptions should include diagnoses

Virginia high school admissions case could be legal follow

The battle over the Brookhaven Landfill on Long Island

Jerome Adams on the need for new antivirals for Covid

Colonoscopy at 40? Study finds a possible benefit

Sports medicine is finally prioritizing gender equality

FDA drug safety: Singulair case shows systemic surveillance flaws

Wildfire smoke exposes gaps in outdoor worker protections

Novo Nordisk to expand supply of Wegovy for U.S. patients

focus

Cognito secures funding to test medical device for Alzheimer's

Cybersecurity threat forces Lurie Children's to take systems offline

New Ultima Genomics DNA sequencer can read genome for $100

In areas with more Black doctors, Black people live longer

New Ultima Genomics DNA sequencer can read genome for $100

Do digital therapeutics have a future in medicine?

hotspot

leisure time

focus

knowledge